Cargando…

Cardiac Safety of High-dose Micafungin

Detalles Bibliográficos
Autores principales:	Stover, Kayla R., Cleary, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642128/ https://www.ncbi.nlm.nih.gov/pubmed/29081623 http://dx.doi.org/10.4103/jpp.JPP_37_17

Ejemplares similares

Are we near to the end of the standard dose of micafungin?
por: Agrifoglio, Alexander, et al.
Publicado: (2018)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
por: Keck, J. Myles, et al.
Publicado: (2023)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

Very-low-birth-weight infants, prophylactic micafungin or fluconazole
por: Gonzalez-Granado, Luis
Publicado: (2010)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study
por: Kobayashi, Chie, et al.
Publicado: (2015)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
por: Undre, Nasrullah, et al.
Publicado: (2014)

Micafungin in the treatment of candiduria: A case series
por: Kane, Lauren E., et al.
Publicado: (2016)

A Case of Endogenous Trichosporon Endophthalmitis Treated with Micafungin and Voriconazole
por: Walia, Harpreet, et al.
Publicado: (2009)

Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
por: Maras, Bruno, et al.
Publicado: (2014)

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
por: Park, Hyunkyung, et al.
Publicado: (2019)

Micafungin: an evidence-based review of its place in therapy
por: de la Torre, Pola, et al.
Publicado: (2014)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2015)

Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex
por: Marx, Jana, et al.
Publicado: (2020)

Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
por: Suh, Jin Woong, et al.
Publicado: (2020)

A Case of Auto-brewery Syndrome Treated with Micafungin
por: Saverimuttu, Jessie, et al.
Publicado: (2019)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
por: Kotsopoulou, Maria, et al.
Publicado: (2019)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Improving the production of the micafungin precursor FR901379 in an industrial production strain
por: Men, Ping, et al.
Publicado: (2023)

Erratum to: Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2015)

1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
por: Piche, Mackenzie, et al.
Publicado: (2020)

Drug–laboratory interaction between beta-lactam antibiotics and the galactomannan antigen test used to detect mould infections
por: Otting, Kristin A., et al.
Publicado: (2014)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
por: Saliba, Faouzi, et al.
Publicado: (2015)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis
por: Gil-Alonso, Sandra, et al.
Publicado: (2015)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
por: Williams, Kelsey N, et al.
Publicado: (2020)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_307ptogmm25bchjr0vvf415j1a